411 related articles for article (PubMed ID: 29579768)
21. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
22. Current views on chronic rejection after lung transplantation.
Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
[TBL] [Abstract][Full Text] [Related]
23. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation.
Evans RA; Walter KS; Lobo LJ; Coakley R; Doligalski CT
Clin Transplant; 2022 Aug; 36(8):e14770. PubMed ID: 35801376
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
26. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppression: Have We Learnt Anything?
Hachem RR
Semin Respir Crit Care Med; 2018 Apr; 39(2):172-180. PubMed ID: 29579769
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive methods for detection of chronic lung allograft dysfunction in lung transplantation.
Tian D; Huang H; Wen HY
Transplant Rev (Orlando); 2020 Jul; 34(3):100547. PubMed ID: 32498976
[TBL] [Abstract][Full Text] [Related]
29. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
[TBL] [Abstract][Full Text] [Related]
31. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
32. Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers.
Tissot A; Danger R; Claustre J; Magnan A; Brouard S
Front Immunol; 2019; 10():1681. PubMed ID: 31379869
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.
Gauthier JM; Ruiz-Pérez D; Li W; Hachem RR; Puri V; Gelman AE; Kreisel D
Transplantation; 2018 Sep; 102(9):1459-1466. PubMed ID: 29683998
[TBL] [Abstract][Full Text] [Related]
34. Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.
Szczepanik A; Hulbert A; Lee HJ; Benedetti C; Snyder L; Byrns J
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29151274
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in lung transplantation.
Sureshbabu A; Fleming T; Mohanakumar T
Transpl Int; 2020 Jan; 33(1):41-49. PubMed ID: 31393646
[TBL] [Abstract][Full Text] [Related]
36. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
37. Emerging biomarkers in chronic lung allograft dysfunction.
Shtraichman O; Diamond JM
Expert Rev Mol Diagn; 2020 May; 20(5):467-475. PubMed ID: 32133875
[No Abstract] [Full Text] [Related]
38. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
39. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
[TBL] [Abstract][Full Text] [Related]
40. Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.
Weigt SS; DerHovanessian A; Wallace WD; Lynch JP; Belperio JA
Semin Respir Crit Care Med; 2013 Jun; 34(3):336-51. PubMed ID: 23821508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
